if the reason its going up is based on a bona fide breakthrough, don't sell. They have already demonstrated the tech works for one drug. If oral insulin works then I would hold forever until they are close to a cure for diabetes. Market cap will go in excess of 3 billion which means 90 to 100 bucks a share. Then they can work on more oral drugs, make strategic acquisitions if they are not bought out first. The latter would seem all too extremely likely so selling before is out of the question.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.